Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer
Abstract
Photodynamic therapy (PDT) using a conventional photosensitizer was approved for esophageal cancer in the early 1990s; however, it was replaced by other conventional treatment modalities in clinical practice because of the high frequency of cutaneous phototoxicity and esophageal stricture after the procedure. The second-generation photosensitizer, talaporfin sodium, which features more rapid clearance from the body, was developed to reduce skin...
Paper Details
Title
Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer
Published Date
Jun 24, 2021
Journal
Volume
10
Issue
13
Pages
2785 - 2785
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History